Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nat Genet. 2022 Oct;54(10):1572-1580. doi: 10.1038/s41588-022-01167-z. Epub 2022 Sep 1.
Single-cell RNA sequencing (scRNA-seq) provides unique insights into the pathology and cellular origin of disease. We introduce single-cell disease relevance score (scDRS), an approach that links scRNA-seq with polygenic disease risk at single-cell resolution, independent of annotated cell types. scDRS identifies cells exhibiting excess expression across disease-associated genes implicated by genome-wide association studies (GWASs). We applied scDRS to 74 diseases/traits and 1.3 million single-cell gene-expression profiles across 31 tissues/organs. Cell-type-level results broadly recapitulated known cell-type-disease associations. Individual-cell-level results identified subpopulations of disease-associated cells not captured by existing cell-type labels, including T cell subpopulations associated with inflammatory bowel disease, partially characterized by their effector-like states; neuron subpopulations associated with schizophrenia, partially characterized by their spatial locations; and hepatocyte subpopulations associated with triglyceride levels, partially characterized by their higher ploidy levels. Genes whose expression was correlated with the scDRS score across cells (reflecting coexpression with GWAS disease-associated genes) were strongly enriched for gold-standard drug target and Mendelian disease genes.
单细胞 RNA 测序 (scRNA-seq) 为疾病的病理学和细胞起源提供了独特的见解。我们引入了单细胞疾病相关性评分 (scDRS),这是一种将 scRNA-seq 与多基因疾病风险在单细胞分辨率上联系起来的方法,与注释的细胞类型无关。scDRS 识别出在全基因组关联研究 (GWAS) 中涉及的疾病相关基因中表达过度的细胞。我们将 scDRS 应用于 74 种疾病/特征和 31 种组织/器官的 130 万单细胞基因表达谱。细胞类型水平的结果广泛概括了已知的细胞类型-疾病关联。单细胞水平的结果鉴定了与现有细胞类型标签未捕获的疾病相关细胞的亚群,包括与炎症性肠病相关的 T 细胞亚群,其特征部分为效应样状态;与精神分裂症相关的神经元亚群,其特征部分为空间位置;与甘油三酯水平相关的肝细胞亚群,其特征部分为较高的倍性水平。在细胞之间与 scDRS 评分相关的基因(反映与 GWAS 疾病相关基因的共表达)在金标准药物靶点和孟德尔疾病基因中强烈富集。